CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


23-November-2010
Cerilliant Introduces New Certified Spiking Solution® of N-Desethylamiodarone-D4 HCl

N-Desethylamiodarone-D4 HCl, D-056
100 ug/mL (as free base) in Methanol

A Certified Spiking Solution® and stable-labeled internal standard for use in therapeutic drug monitoring analyses by LC/MS. N-Desethylamiodarone is the primary, active metabolite of amiodarone, an antiarrhythmic agent marketed as Pacerone, Cordarone, Aratac, or Atlansi. N-Desethylamiodarone and amiodarone are monitored by clinical labs to ensure patients remain within the drug’s therapeutic range.

In addition to amiodarone (A-060), its stable-labeled internal standard (A-083) and native N-Desethylamiodarone (D-055), we offer certified solution standards of other antiarrhythmic drugs as well as antihypertensive and cardiac drugs. We also offer Certified Spiking Solutions® of numerous drugs assayed in therapeutic drug monitoring.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn